Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis.
Lindsey JW, Hodgkinson S, Mehta R, Siegel RC, Mitchell DJ, Lim M, Piercy C, Tram T, Dorfman L, Enzmann D, et al.
Lindsey JW, et al. Among authors: mehta r.
Neurology. 1994 Mar;44(3 Pt 1):413-9. doi: 10.1212/wnl.44.3_part_1.413.
Neurology. 1994.
PMID: 8145907
Clinical Trial.